1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Convalescent plasma treatment in severely immunosuppressed patients hospitalized with COVID-19: an observational study of 28 cases
- Contribution to journal › Article
-
Mark
A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome : No Evidence of Benefit, Supported by Epidemiology and In Vitro Data
- Contribution to journal › Article
- 2021
-
Mark
Convalescence plasma treatment of COVID-19 : results from a prematurely terminated randomized controlled open-label study in Southern Sweden
Holm, Karin LU ; Lundgren, Maria N LU ; Kjeldsen-Kragh, Jens LU ; Ljungquist, Oskar LU ; Böttiger, Blenda LU ; Wikén, Christian ; Öberg, Jonas LU
; Fernström, Nils
; Rosendal, Ebba
and Överby, Anna K
LU
, et al.
(2021)
In BMC Research Notes
14.
p.1-5
- Contribution to journal › Article
-
Mark
COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19) : a structured summary of a study protocol for a randomised controlled trial
- Contribution to journal › Letter